Singapore: The National Institutes of Health (NIH) is funding $45 million for research aimed at preventing Alzheimer's ...
Singapore: Singapore's emerging company Clearbridge BioMedics plans to launch its ClearCell FX System at American Societ...
Singapore: The US Food and Drug Administration (FDA) has accepted Australia-based CSL Behring's biologics license applic...
Singapore: Japan-based biopharmaceutical firm, Kyowa Hakko Kirin (KHK) has setup Singapore Translational Research Labora...
Singapore: AB Sciex, a global leader in analytical technologies, has launched MasterView Software, a new software applic...
Singapore: Australia-based Living Cell Technologies (LCT) has implanted regenerative cell therapy NTCELL, a treatment fo...
Singapore: GlaxoSmithKline's (GSK) Dermai study, a phase III, randomized, blinded, placebo-controlled Mage-A3 cancer imm...
Singapore: The Health Sciences Authority (HSA) of Singapore has approved Bayer' Stivarga, the first oral targeted therap...
Singapore: European Forum Against Blindness (EFAB) has revealed the results of a six-country study which analyzed the ec...
Singapore: Gilead Sciences has submitted a New Drug Application (NDA) to the US FDA for approval of sofosbuvir, a once-d...
Singapore: Gilead Sciences' phase II study (Study 101-08) evaluating idelalisib (formerly GS-1101), an investigational, ...
Bangalore: Advinus Therapeutics, a Bangalore-based drug discovery and development company, and P2D Bioscience, a CNS-foc...
What is Glivec?Glivec or imatinib mesylate is the first of a class of drugs that specifically inhibits a target enzyme, ...
Singapore: A new report by healthcare experts GlobalData has revealed that on cytomegalovirus (CMV), which is generall...
Singapore: Israel-based Sol-Gel Technologies achieved positive results for a phase II trial in the US targeting mild-to-...
Singapore: The Indian Ministry of Health and Family Welfare has notified the draft rules on a new domain of medicines ca...
Singapore: The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted...
Singapore: The US FDA has cancelled an advisory committee meeting that was scheduled to be held on July 18, 2013, in ord...
